GenSight Biologics S.A. (LON:0RIM)
London · Delayed Price · Currency is GBP · Price in EUR 0.0788
-0.0025 (-3.02%)
At close: Feb 11, 2026
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of 15.75 million as of February 12, 2026. Its market cap has decreased by -49.88% in one year.
Market Cap
15.75M
Enterprise Value
32.08M
Revenue
810.05K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 212.26M to 15.75M, a decrease of -92.58%. That is a compound annual growth rate of -23.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 15.03M | -25.14% |
| Dec 31, 2025 | 20.08M | -26.53% |
| Dec 31, 2024 | 27.33M | 22.73% |
| Dec 29, 2023 | 22.27M | -83.82% |
| Dec 30, 2022 | 137.66M | -35.82% |
| Dec 31, 2021 | 214.49M | -21.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solvonis Therapeutics | 17.70M |
| Ground Rents Income Fund | 17.22M |
| Hydrogen Capital Growth | 17.20M |
| Aseana Properties | 15.92M |
| IMC Exploration Group | 15.61M |
| Videndum | 14.50M |
| Harena Rare Earths | 13.63M |
| LMS Capital | 13.36M |